Showing results (3111-3120 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|July 31, 2017
Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing EvidenceJan Norum, Carsten Nieder
Pharmacoeconomics|September 2, 2017
Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current LiteratureHamzeh Albaba, Charles Lim, Natasha B Leighl
Pharmacoeconomics|August 4, 2017
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHazel Squires, Abdullah Pandor, Praveen Thokala, et al.
Pharmacoeconomics|July 6, 2016
BEACON: A Summary Framework to Overcome Potential Reimbursement HurdlesWilliam C N Dunlop, C Daniel Mullins, Olaf Pirk, et al.
Pharmacoeconomics|September 13, 2017
Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated ReviewAlisha Monnette, Yichen Zhang, Hui Shao, et al.
Pharmacoeconomics|July 16, 2017
Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile EquatingNicolas R Thompson, Brittany R Lapin, Irene L Katzan
Pharmacoeconomics|May 1, 2016
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast CancerPieter T de Boer, Geert W J Frederix, Talitha L Feenstra, et al.
Pharmacoeconomics|November 25, 2020
Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid LeukemiaCarla Mamolo, Verna Welch, Roland B Walter, et al.
Pharmacoeconomics|November 4, 2020
The Budget Impact of Including Rucaparib on a US Payer Formulary for the Treatment of Patients with Metastatic Ovarian CancerKatrine Wallace, Kelly Adamski, Ashwini Pai, et al.
Pharmacoeconomics|November 5, 2020
Evaluating New Zealanders' Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common ConditionsLinda Yamoah, Nick Dragojlovic, Alesha Smith, et al.
Pageof 336